M Jeffrey Selected Research

Gliosis

8/2011	Neuropathological changes correlate temporally but not spatially with selected neuromodulatory responses in natural scrapie.
6/2009	Abnormal prion protein is associated with changes of plasma membranes and endocytosis in bovine spongiform encephalopathy (BSE)-affected cattle brains.
8/2007	Classical sheep transmissible spongiform encephalopathies: pathogenesis, pathological phenotypes and clinical disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Jeffrey Research Topics

Disease

29	Scrapie 04/2017 - 01/2000
15	Infections 01/2015 - 11/2001
14	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2017 - 07/2000
9	Bovine Spongiform Encephalopathy (Mad Cow Disease) 01/2015 - 01/2004
3	Amyloid Plaque 04/2014 - 01/2001
3	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2013 - 06/2009
3	Gliosis 08/2011 - 08/2007
2	Neoplasm Metastasis (Metastasis) 12/2018 - 09/2005
2	Seizures (Absence Seizure) 01/2014 - 07/2001
2	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 01/2010 - 09/2000
2	Kuru 01/2001 - 01/2001
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Hypertension (High Blood Pressure) 12/2018
1	Neoplasms (Cancer) 12/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2018
1	Tay-Sachs Disease 02/2014
1	CADASIL 10/2013
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2013
1	Amyloidosis 04/2013
1	Alzheimer Disease (Alzheimer's Disease) 04/2013
1	Cerebral Palsy (Spastic Diplegia) 08/2012
1	Nervous System Diseases (Neurological Disorders) 07/2012
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2007

Drug/Important Bio-Agent (IBA)

35	Prion ProteinsIBA 04/2017 - 04/2000
16	Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugateIBA 01/2015 - 01/2002
4	Amyloid (Amyloid Fibrils)IBA 04/2017 - 01/2001
4	Codon (Codons)IBA 01/2015 - 10/2000
4	PrPSc ProteinsIBA 05/2006 - 07/2000
3	Proteins (Proteins, Gene)FDA Link 10/2013 - 06/2009
3	PrionsIBA 10/2013 - 03/2009
2	Glutamine (L-Glutamine)FDA Link 01/2015 - 01/2014
2	Methionine (L-Methionine)FDA Link 01/2015 - 04/2013
2	Threonine (L-Threonine)FDA Link 01/2015 - 04/2013
2	Arginine (L-Arginine)FDA Link 01/2015 - 01/2014
2	Valine (L-Valine)FDA Link 01/2014 - 10/2000
2	Protein Isoforms (Isoforms)IBA 06/2009 - 01/2004
2	AntibodiesIBA 02/2006 - 01/2006
2	Peptide Hydrolases (Proteases)FDA Link 01/2006 - 07/2000
2	Peptides (Polypeptides)IBA 01/2006 - 11/2001
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 12/2018
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2018
1	Cetuximab (Erbitux)FDA Link 12/2018
1	ClathrinIBA 04/2017
1	Alanine (L-Alanine)FDA Link 01/2015
1	Hexosaminidase A (Hex A)IBA 02/2014
1	Finasteride (Propecia)FDA LinkGeneric 01/2014
1	Midazolam (Versed)FDA LinkGeneric 01/2014
1	Progesterone FDA LinkGeneric 01/2014
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2014
1	Amyloid beta-PeptidesIBA 10/2013
1	Peptide FragmentsIBA 04/2013
1	tau Proteins (tau Protein)IBA 04/2013
1	ParvalbuminsIBA 08/2011
1	SynaptophysinIBA 08/2011
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 08/2011
1	SolutionsIBA 05/2006
1	Sucrose (Saccharose)IBA 05/2006
1	EpitopesIBA 02/2006
1	Caspase 3 (Caspase-3)IBA 11/2001
1	PACAP-related peptideIBA 11/2001
1	Amino Acids FDA Link 11/2001
1	3,4-dihydroxyphenylglycolIBA 07/2001
1	LY 379268IBA 07/2001
1	LY 389795IBA 07/2001
1	Coloring Agents (Dyes)IBA 01/2001
1	PrPC ProteinsIBA 07/2000
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2000
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2000

Therapy/Procedure

2	Therapeutics 10/2013 - 09/2000
1	Oral Administration 01/2014
1	Immunotherapy 10/2013
1	Lymph Node Excision (Lymph Node Dissection) 04/2013
1	Blood Transfusion (Blood Transfusions) 01/2010
1	Mastectomy (Mammectomy) 09/2005
1	Lasers (Laser) 04/2000